Russia agrees to supply 35mn doses of Covid-19 vaccine to Uzbekistan
September 25 2020 10:40 AM
A nurse prepares Russia's "Sputnik-V" vaccine against the coronavirus disease for inoculation in a p
A nurse prepares Russia's "Sputnik-V" vaccine against the coronavirus disease (Covid-19) for inoculation in a post-registration trials stage at a clinic in Moscow, Russia September 17, 2020

Reuters/Moscow

Russia's sovereign wealth fund said on Friday it had agreed to supply up to 35 million doses of the Russian experimental vaccine against Covid-19 to Uzbekistan's Laxisam, a pharmaceutical company.
The deal is one of several agreed by the Russian Direct Investment Fund (RDIF) in recent weeks to supply the vaccine, which is currently being tested in a large-scale trial in Moscow, abroad.
It has also inked supply deals with Kazakhstan, India, Mexico and two states in Brazil.



There are no comments.

LEAVE A COMMENT Your email address will not be published. Required fields are marked*
MORE NEWS

HAPPENING IN DOHAMore